Prognostic value of CXLC 9 in patients undergoing neoadjuvant radiochemotherapy and surgery in stage IIIA NSCLC.

e24156Background: Neoadjuvant radiochemotherapy is an established strategy to downgrade and downsize locally progredient NSCLC to become curatively resected. Upon tumor regression tumor antigens be...